Haemonetics (HAE) Current Assets (2010 - 2026)

Haemonetics has reported Current Assets for 17 years, with the latest figure at $834.9 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 10.71% year-over-year to $834.9 million; the trailing twelve-month figure through Mar 2026 stood at $834.9 million (down 10.71% YoY), and the FY2026 full-year result was $834.9 million, down 10.71% from the prior year.
• Current Assets for Q1 2026 stood at $834.9 million, down from $943.7 million in the prior quarter.
• The five-year high for Current Assets was $1.0 billion in Q4 2024, with the low at $687.8 million in Q3 2022.
• Average Current Assets over 5 years is $835.2 million, with a median of $818.2 million recorded in 2023.
• Year-over-year, Current Assets surged 31.49% in 2024 and retreated 10.71% in 2026.
• Tracing HAE's Current Assets over 5 years: stood at $706.3 million in 2022, then gained by 8.31% to $765.0 million in 2023, then jumped by 31.49% to $1.0 billion in 2024, then declined by 6.18% to $943.7 million in 2025, then fell by 11.53% to $834.9 million in 2026.
• The last three Current Assets figures came in at $834.9 million (Q1 2026), $943.7 million (Q4 2025), and $899.7 million (Q3 2025), per Business Quant data.

Peer Comparison